Search results for "Zen"

showing 10 items of 3479 documents

Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study

2011

Studies have demonstrated that the acute administration of 3-hydroxy-3 methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors has protective effects in the setting of ischemia-reperfusion (IR). Previously, we demonstrated that a single dose of rosuvastatin prevented IR-induced endothelial dysfunction in humans through a cyclooxygenase-2-dependent mechanism. Whether the chronic administration of HMG-CoA reductase inhibitors provides similar protection remains controversial and is unknown in humans. Eighteen male volunteers were randomized to receive a single dose of rosuvastatin (20 mg) or placebo. Twenty-four hours later, endothelium-dependent, radial artery flow-mediated dilation (FMD) w…

AdultMaleTime FactorsAdolescentEndotheliumPhysiologyCoenzyme AHyperemiaPharmacologyReductaseDrug Administration ScheduleYoung Adultchemistry.chemical_compoundDouble-Blind MethodIschemiaIn vivoPhysiology (medical)medicineHumansRosuvastatinRosuvastatin CalciumOntarioAnalysis of VarianceSulfonamidesCyclooxygenase 2 Inhibitorsbiologybusiness.industryFluorobenzenesVasodilationRosuvastatin CalciumPyrimidinesmedicine.anatomical_structurechemistryCelecoxibRegional Blood FlowReperfusion InjuryRadial ArteryHMG-CoA reductasebiology.proteinCelecoxibPyrazolesHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessBlood Flow Velocitymedicine.drugAmerican Journal of Physiology-Heart and Circulatory Physiology
researchProduct

Time Course of 5-HT2A Receptor Occupancy in the Human Brain after a Single Oral Dose of the Putative Antipsychotic Drug MDL 100,907 Measured by Posit…

1997

MDL 100,907 is a potent and selective antagonist of 5-HT2A serotonin receptors. Animals studies suggest that MDL 100,907 may behave as an atypical antipsychotic drug. Positron emission tomograph (PET) using [11C]NMSP as the radiotracer was used to define the time course of 5-HT2 receptor occupancy in the human frontal cerebral cortex after a single oral dose of MDL 100,907 (10 or 20 mg) in nine healthy subjects. After the baseline scan each subject was studied three times post dosing at various time points. 5-HT2 occupancies were in the range of 70 and 90% after each dose. While the occupancy remains in this range over 24 hours after 20 mg MDL 100,907, it decreases by about 20% at 24 hours …

AdultMaleTime Factorsmedicine.drug_classAtypical antipsychoticPharmacologyPiperidinesOral administrationmedicineHumansReceptor Serotonin 5-HT2ACarbon RadioisotopesPositron emissionDosing5-HT receptorPharmacologymedicine.diagnostic_testbusiness.industry5-HT2 receptorBrainHuman brainFluorobenzenesPsychiatry and Mental healthmedicine.anatomical_structureSpiperonePositron emission tomographyReceptors SerotoninFemaleSerotonin AntagonistsbusinessAntipsychotic AgentsTomography Emission-ComputedNeuropsychopharmacology
researchProduct

Sporting habits of urban runners: Classification according to their motivation

2019

This study analyses the sporting habits of runners participating in short-distance urban running events to identify groups with different motivations towards the practice of endurance running and participation in urban running events. A sample consisting of 937 participants in the Valencia running circuit was interviewed using a questionnaire consisting of a scale of 22 items to analyse their motives for participating in popular races. An exploratory and confirmatory factorial analysis was carried out to check the validity of the instrument, and the analysis identified the following four factors into which the indicators were grouped: psychological and physical motives (3 items), social mot…

AdultMaleTypologyUrban PopulationHealth Toxicology and MutagenesisApplied psychologySample (statistics)ArticleRunningHabits03 medical and health sciences0302 clinical medicinemotivesurban runnersSurveys and Questionnairescitizens’ sports habitsHumans0501 psychology and cognitive sciences030212 general & internal medicineclustersrunnersEsportsMotivation05 social sciencesPublic Health Environmental and Occupational HealthMiddle AgedSocial recognition050106 general psychology & cognitive sciencesAnnual incomeCorredors (Esports)Scale (social sciences)FemaleFactorial analysistypologysportsPsychology
researchProduct

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab.

2018

Background Autoimmune thrombotic thrombocytopenic purpura (iTTP) is caused by autoantibody-mediated severe a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13 (ADAMTS13) deficiency leading to micro-angiopathic haemolytic anaemia (MAHA) and thrombocytopenia with organ damage. Patients survive with plasma exchange (PEX), fresh frozen plasma replacement and corticosteroid treatment. Anti-CD20 monoclonal antibody rituximab is increasingly used in patients resistant to conventional PEX or relapsing after an acute bout. Objective This retrospective observational study focused on the relapse rate and possible influencing factors including treatment with rituximab first…

AdultMalemedicine.medical_specialtyAdolescentautoantibodiesThrombotic thrombocytopenic purpuraADAMTS13 ProteinRelapse rate030204 cardiovascular system & hematologyGastroenterologyAutoimmune Diseases03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsRecurrenceInternal medicinehemic and lymphatic diseasesCellular Haemostasis and PlateletsMedicineHumansImmunologic Factorsclinical studiesYoung adultChildADAMS/ADAMTS13Retrospective StudiesPurpura Thrombotic Thrombocytopenicbusiness.industryRetrospective cohort studyHematologythrombotic thrombocytopenic purpura (TTP/HUS)Middle Agedmedicine.diseaseAntigens CD20ADAMTS13PurpuraTreatment Outcome030220 oncology & carcinogenesisRituximabFemaleFresh frozen plasmamedicine.symptombusinessRituximabmedicine.drugFollow-Up StudiesThrombosis and haemostasis
researchProduct

Correlation between Density and Resorption of Fresh-Frozen and Autogenous Bone Grafts

2014

Trial Design. This analysis compared the outcome of fresh-frozen versus autologous bone block grafts for horizontal ridge augmentation in patients with Cawood and Howell class IV atrophies.Methods. Seventeen patients received autologous grafts and 21 patients received fresh-frozen bone grafts. Patients underwent CT scans 1 week and 6 months after surgery for graft volume and density analysis.Results. Two autologous and 3 fresh-frozen grafts failed. Autologous and fresh-frozen grafts lost, respectively, 28% and 46% of their initial volume(P=0.028). It is noteworthy that less dense fresh-frozen blocks lost more volume than denser grafts (61% versus 16%).Conclusions. According to these 6-month…

AdultMalemedicine.medical_specialtyArticle SubjectBone densitylcsh:MedicineTransplantation AutologousGeneral Biochemistry Genetics and Molecular BiologyBone resorptionYoung AdultBone DensityAlveolar ProcessmedicineFrozen SectionsHumansIn patientBone ResorptionAutogenous bonedensity and resorptionFrozen section procedureBone TransplantationGeneral Immunology and Microbiologybusiness.industryAlveolar processlcsh:RGeneral MedicineMiddle Agedfresh-frozen bone graftsAUTOGENOUS BONEResorptionSurgerymedicine.anatomical_structureClinical StudyFresh frozenFemalebusinessBioMed Research International
researchProduct

Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease

1980

The cardiovascular effects of a single i.v. dose (2 mg/kg over 5 min) of lorcainide were studied in 14 patients with heart disease. In the haemodynamic part of the study (6 patients), the aortic and pulmonary systolic, diastolic and mean pressures, left ventricular systolic and end-diastolic pressures, cardiac output and the rate of rise of left ventricular pressure were measured before and for 30 min after administration of the drug. Lorcainide produced a slight and short-lasting decrease in the aortic and pulmonary systolic pressures, and all other pressure values remained unchanged. The cardiac output and systemic vascular resistance were not altered by lorcainide. It consistently depres…

AdultMalemedicine.medical_specialtyCardiac outputTime FactorsHeart DiseasesHeart diseaseBenzeneacetamidesDiastoleHemodynamicsBlood PressureLorcainidePiperidinesInternal medicinemedicineHumansPharmacology (medical)Cardiac OutputAgedPharmacologyEjection fractionbusiness.industryHeartGeneral MedicineMiddle Agedmedicine.diseaseMyocardial Contractionmedicine.anatomical_structureAnesthesiaVascular resistanceVentricular pressureCardiologyFemaleVascular ResistancebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Prenatal Exposure to Organochlorine Compounds and Birth Size

2011

Objective: To investigate the possible association between birth size and cord concentrations of some organochlorine compounds (OCs), including 4,4′-dichlorodiphenyltrichloroethane (DDT), 4,4′-1,1-dichloro-2,2-bis(p-dichlorodiphenyl)ethylene (DDE), hexachlorobenzene (HCB), β-hexachlorocyclohexane (β-HCH), 4 polychlorinated biphenyl (PCB) congeners (118, 138, 153, and 180), and their sum (ΣPCBs) in a birth cohort in Valencia, Spain. Study Design: A total of 494 mothers and their newborns (born 2003–2006) participated in the study. Multivariate linear regression analyses were performed between birth weight, length, or head circumference and OC concentrations. Results: Median concentrations of…

AdultMalemedicine.medical_specialtyCordCephalometryBirth weightLengthPhysiologyHead circumferenceUmbilical cordDDTFetal Developmentchemistry.chemical_compoundBirth weightInternal medicinemedicineHydrocarbons ChlorinatedBody SizeHumansProspective StudiesHCBHCHFetusPCBbusiness.industryInfant NewbornPolychlorinated biphenylHexachlorobenzeneAnthropometrymedicine.anatomical_structureEndocrinologychemistryPediatrics Perinatology and Child HealthDDEFemaleLindanebusiness
researchProduct

Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary fin…

2007

The aim of the present study was to evaluate the safety and efficacy of the combination of indomethacin and statin compared with indomethacin plus placebo in patients with a first episode of pericarditis. A total of 55 consecutive patients with acute pericarditis were randomized in a double-blind manner into two groups: group I (statin group) was treated with 150 mg of indomethacin plus 10 mg of rosuvastatin, and group 2 (placebo group) was treated with 150 mg of indomethacin plus placebo. Both groups received treatment up to the normalization of inflammation markers and for the following week. Clinical and laboratory assessments [white cell count, ESR (erythrocyte sedimentation rate) and C…

AdultMalemedicine.medical_specialtyIndomethacinPlaceboGastroenterologyElectrocardiographyPericarditisAcute pericarditisDouble-Blind MethodRecurrenceInternal medicineTroponin ImedicineHumansPericarditisRosuvastatinRosuvastatin CalciumPericarditis Colchicine Postpericardiotomy syndromeFirst episodeSulfonamidesmedicine.diagnostic_testbiologybusiness.industryAnti-Inflammatory Agents Non-SteroidalCardiovascular AgentsGeneral Medicinemedicine.diseaseSurgeryFluorobenzenesC-Reactive ProteinPyrimidinesTreatment OutcomeErythrocyte sedimentation rateAcute Diseasebiology.proteinDrug Therapy CombinationFemaleCreatine kinaseHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsbusinessFollow-Up Studiesmedicine.drugClinical Science
researchProduct

Comparison of131I-metaiodobenzylguanidine scintigraphy with urinary and plasma catecholamine determinations in the diagnosis of pheochromocytoma

1985

In a retrospective study of 31 patients with suspected pheochromocytoma we examined the preoperative results of 131I-metaiodobenzylguanidine (131-I-MIBG) scintigraphy and a fluorimetric urine catecholamine determination test. An additional radioenzymatic plasma catecholamine determination test was performed in 25 patients. In 14 of the 31 patients the diagnosis of pheochromocytoma was later histologically confirmed. In the remaining 17 patients the suspected diagnosis was finally rejected after a clinical decision had been made on the basis of clinical history, symptoms, laboratory and imaging tests. 131-I-MIBG scintigraphy apparently had a very high specificity (no false-positive results a…

AdultMalemedicine.medical_specialtyPathologyUrinary systemAdrenal Gland NeoplasmsUrologyPheochromocytomaUrineScintigraphyHigh-performance liquid chromatographyPheochromocytomaCatecholaminesPathognomonicDrug DiscoverymedicineHumansRadionuclide ImagingGenetics (clinical)AgedRetrospective Studiesmedicine.diagnostic_testIodobenzenesbusiness.industryRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.disease3-IodobenzylguanidineCatecholamineMolecular MedicineFemalebusinessmedicine.drugKlinische Wochenschrift
researchProduct

Lifetime, 5-year and past-year prevalence of homelessness in Europe: a cross-national survey in eight European nations

2019

ObjectivesTo examine the lifetime, 5-year and past-year prevalence of homelessness among European citizens in eight European nations.DesignA nationally representative telephone survey using trained bilingual interviewers and computer-assisted telephone interview software.SettingThe study was conducted in France, Ireland, Italy, the Netherlands, Poland, Portugal, Spain and Sweden.ParticipantsEuropean adult citizens, selected from opt-in panels from March to December 2017. Total desired sample size was 5600, with 700 per country. Expected response rates of approximately 30% led to initial sample sizes of 2500 per country.Main outcome measuresHistory of homelessness was assessed for lifetime, …

AdultMalemedicine.medical_specialtyTime FactorsAdolescent[SDV]Life Sciences [q-bio]prevalenceService useSociodemographic dataHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencesHealth servicesYoung Adult0302 clinical medicineRisk FactorsSurveys and QuestionnairesmedicineHumans1724030212 general & internal medicine150610. No inequalitySociodemographic datahomelessnessAgedOriginal ResearchAged 80 and overbusiness.industryeuropean adult citizensEurope; homelessness; prevalence; public healthCross national surveyPublic health1. No povertyGeneral MedicineMiddle Aged3. Good healthTelephone surveyEuropeTelephone interviewSocioeconomic FactorsSample size determinationIll-Housed PersonsLinear ModelsFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePublic Healthbusiness030217 neurology & neurosurgeryDemographyBMJ Open
researchProduct